Search

Biochemical characteristics of control and breast cancer patients

4.6 (644) · $ 21.50 · In stock

Biochemical characteristics of control and breast cancer patients
Updated guidance on the management of cancer treatment-induced bone loss  (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and  therapeutic intervention - ScienceDirect

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect

Bone turnover: BMD parameters (mg/cm 2 ) between M0 and M12

Bone turnover: BMD parameters (mg/cm 2 ) between M0 and M12

BMD and BMC From the Whole Body and Regional Sites in Soccer Players

BMD and BMC From the Whole Body and Regional Sites in Soccer Players

Biological Characteristics of Breast Cancer among Jordanian Women: A  retrospective Single Center Cohort Study

Biological Characteristics of Breast Cancer among Jordanian Women: A retrospective Single Center Cohort Study

Raman spectroscopy: current applications in breast cancer diagnosis,  challenges and future prospects

Raman spectroscopy: current applications in breast cancer diagnosis, challenges and future prospects

Cigdem Papila's research works  İstanbul University-Cerrahpaşa, Istanbul  and other places

Cigdem Papila's research works İstanbul University-Cerrahpaşa, Istanbul and other places

Samir AHID, Research Director, Pharmacologist, Mohammed V University of  Rabat, Rabat, um5a, Department of Pharmacology & Toxicology

Samir AHID, Research Director, Pharmacologist, Mohammed V University of Rabat, Rabat, um5a, Department of Pharmacology & Toxicology

Biochemical characteristics of control and breast cancer patients.

Biochemical characteristics of control and breast cancer patients.

Frontiers  Molecular Diagnostics in Clinical Oncology

Frontiers Molecular Diagnostics in Clinical Oncology

Mapping molecular subtype specific alterations in breast cancer brain  metastases identifies clinically relevant vulnerabilities

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities